These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38900758)

  • 41. Psychiatrists' and Psychiatry Residents' Attitudes Toward Transgender People.
    Ali N; Fleisher W; Erickson J
    Acad Psychiatry; 2016 Apr; 40(2):268-73. PubMed ID: 25743203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Influence of Genotype Information on Psychiatrists' Treatment Recommendations: More Experienced Clinicians Know Better What to Ignore.
    McMichael AJ; Boeri M; Rolison JJ; Kane J; O'Neill FA; Scarpa R; Kee F
    Value Health; 2017 Jan; 20(1):126-131. PubMed ID: 28212953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clozapine prescribing in a Canadian outpatient population.
    Alessi-Severini S; Le Dorze JA; Nguyen D; Honcharik P; Eleff M
    PLoS One; 2013; 8(12):e83539. PubMed ID: 24358290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia.
    Schachter DC; Kleinman I
    Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.
    Laugharne J; Waterreus AJ; Castle DJ; Dragovic M
    Australas Psychiatry; 2016 Feb; 24(1):62-6. PubMed ID: 26635377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Policy and practice in the management of postnatal depression in Scotland.
    Alder EM; Reid M; Sharp LJ; Cantwell R; Robertson K; Kearney E
    Arch Womens Ment Health; 2008 Jul; 11(3):213-9. PubMed ID: 18493712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Young People With Antipsychotic Medications in the United States.
    Olfson M; King M; Schoenbaum M
    JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic testing in intellectual disability psychiatry: Opinions and practices of UK child and intellectual disability psychiatrists.
    Wolfe K; Stueber K; McQuillin A; Jichi F; Patch C; Flinter F; Strydom A; Bass N
    J Appl Res Intellect Disabil; 2018 Mar; 31(2):273-284. PubMed ID: 28833975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in Japan.
    Tsujii N; Saito T; Izumoto Y; Usami M; Okada T; Negoro H; Iida J
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):642-5. PubMed ID: 26103533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
    Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perceptions of Psychiatrists Toward the Use of Long-Acting Injectable Antipsychotics: An Online Survey Study From India.
    Grover S; Sahoo S; Mehra A
    J Clin Psychopharmacol; 2019; 39(6):611-619. PubMed ID: 31688382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs.
    Ephraim E; Prettyman R
    Int Psychogeriatr; 2009 Jun; 21(3):576-80. PubMed ID: 19257918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
    McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
    BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients' and psychiatrists' perspectives on clozapine treatment-a scoping review protocol.
    Jakobsen MI; Storebø OJ; Austin SF; Nielsen J; Simonsen E
    BMJ Open; 2021 Oct; 11(10):e054308. PubMed ID: 34620673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attitudes towards electroconvulsive therapy among Hungarian psychiatrists.
    Gazdag G; Kocsis N; Tolna J; Lipcsey A
    J ECT; 2004 Dec; 20(4):204-7. PubMed ID: 15591851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescriber and institutional barriers and facilitators of clozapine use: A systematic review.
    Verdoux H; Quiles C; Bachmann CJ; Siskind D
    Schizophr Res; 2018 Nov; 201():10-19. PubMed ID: 29880453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device.
    Kelly DL; Ben-Yoav H; Payne GF; Winkler TE; Chocron SE; Kim E; Kitchen C; Stock V; Vyas G; Love RC; Wehring HJ; Sullivan KM; Feldman S; Liu F; McMahon RP; Ghodssi R
    Clin Schizophr Relat Psychoses; 2018; 12(1):23-30. PubMed ID: 26218235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrasting clozapine prescribing patterns in the east and west?
    Chong SA; Remington GJ; Lee N; Mahendran R
    Ann Acad Med Singap; 2000 Jan; 29(1):75-8. PubMed ID: 10748970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescription attitudes and practices regarding clozapine among Serbian psychiatrists: results of a nationwide survey.
    Ignjatovic Ristic D; Cohen D; Ristic I
    Ther Adv Psychopharmacol; 2021; 11():20451253211020235. PubMed ID: 34104415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.